daunorubicin has been researched along with Thyroid Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreoni, A; Colasanti, A; Kisslinger, A; Mastrocinque, M; Riccio, P; Roberti, G | 1 |
| Andreoni, A; Colasanti, A; Kisslinger, A; Mastrocinque, M; Portella, G; Riccio, P; Roberti, G | 1 |
| Larsson, R; Nygren, P | 1 |
3 other study(ies) available for daunorubicin and Thyroid Neoplasms
| Article | Year |
|---|---|
Fluorometric determination of the kinetics of anthracyclines uptake by cells.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Culture Media; Daunorubicin; Doxorubicin; Epithelial Cells; Epithelium; Extracellular Space; Fluorometry; Lipoproteins, LDL; Lung Neoplasms; Neoplasms; Rats; Spectrometry, Fluorescence; Thyroid Gland; Thyroid Neoplasms | 1994 |
Enhanced response to daunomycin of normal, tumor and metastatic cell lines via drug photoactivation.
Topics: Animals; Biological Transport; Cell Line; Cell Survival; Darkness; Daunorubicin; Light; Lung Neoplasms; Rats; Rats, Inbred F344; Thyroid Gland; Thyroid Neoplasms; Tumor Cells, Cultured | 1993 |
Verapamil and cyclosporin A potentiate the effects of chemotherapeutic drugs in the human medullary thyroid carcinoma TT cell line not expressing the 170 kDa P-glycoprotein.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Etoposide; Humans; Membrane Glycoproteins; Thyroid Neoplasms; Tumor Cells, Cultured; Verapamil; Vincristine | 1990 |